January 7, 2019 Outbreak News Today Vaccines: Valneva announces positive Phase 1 interim results for Chikungunya vaccine candidate
January 7, 2019 Precision Vaccinations Chikungunya Vaccine Candidate Reports 100% Seroconversion Rate
December 30, 2018 Outbreak News Today Podcast Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach
December 19, 2018 FiercePharma Valneva’s Lyme vaccine—the only active candidate out there—moves to phase 2
December 17, 2018 Outbreak News Today Lyme Disease vaccine candidate enters Phase 2 clinical development
December 17, 2018 Drug Development Technology Valneva starts Phase ll trial of VLA15 to treat Lyme disease